Mayes, Gregory T.
SEC-identified person · CIK 1424630 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Aveo Pharmaceuticals, INC. AVEO | Director | filed 2019–2023 |
| Oncosec Medical Inc ONCS.OB | Director | filed 2018–2019 |
| Ayala Pharmaceuticals, Inc. ADXS | Director · Chief Operating Officer | filed 2013–2017 |
| Dendreon Corp DNDNQ | EVP Human Resources | filed 2013–2013 |
| Unigene Laboratories INC UGNE | Director · VP, Corporate Affairs | filed 2010–2012 |
| Imclone Systems INC/DE IMCL | VP, Interim General Counsel | filed 2008–2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.